Medical App highlights ultrasonic wound debridement.
Press Release Summary:
Designed for iPads, SonicOne O.R. app educates users on benefits of ultrasonic wound debridement using SonicOne technology. Users can explore science behind SonicOne O.R. with 3D animation of ultrasound technology, witness macro and microscopic interaction of ultrasound in wound environment, and observe surgical technique used for debriding wounds in 3D wound animation. App also contains material on SonicOne O.R.'s clinical and economic benefits, key publications, and endorsements.
Original Press Release:
Misonix, Inc. Unveils New SonicOne® O.R. App to Highlight Advantages of Ultrasonic Wound Debridement in Acute and Chronic Wounds
FARMINGDALE, N.Y. -- Misonix, Inc. (NASDAQ: MSON), an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, skull based surgery, neurosurgery, wound debridement, cosmetic surgery, laparoscopic surgery and other surgical applications, announced the launch of its SonicOne O.R. app for iPad mobile devices.
The new iPad app was designed to educate users on the extensive benefits of ultrasonic wound debridement using the SonicOne technology. Users can explore the science behind the SonicOne O.R. with 3D animation of the innovative ultrasound technology, witness the macro and microscopic interaction of ultrasound in a wound environment, and observe the surgical technique used for debriding a wound in the 3D wound animation. The app also contains extensive material on SonicOne O.R.'s clinical and economic benefits, key publications and endorsements from distinguished surgeons who have made SonicOne a standard of care in their practice.
Commenting on the new app, Dr. David Pougatsch, attending & teaching faculty member in the department of Surgery at Cedars-Sinai Medical Center in Los Angeles, CA and Director of the Sherman Oaks Hospital Amputation Prevention Center said, "I've been very impressed with the SonicOne O.R. over the past two years and it has become a standard of care in our treatment protocols for some of the most challenging cases in preventing limb amputations. This new digital content, now available on the iTunes store, allows the clinicians to gain a more comprehensive understanding of how this advanced technology works and will become a great educational tool for new surgeons. Additionally, we will now have a fantastic mobile tool for showing our patients exactly what this therapy and treatment is doing. This app does a wonderful job in distilling some very technical microbiologic information regarding the SonicOne O.R. mechanism of action into an easy to understand animation for patients and non-clinical viewers."
"This new iPad app continues our commitment to develop new tools to better communicate with our rapidly expanding global customer base and international stakeholders," said Michael A. McManus, Jr., President and Chief Executive Officer of Misonix. "We have continued to expand our digital platform through regular updates to include new information, surgical videos, product offerings and functionality, which will be available in the Apple iTunes store. Surgeons around the world now have direct access to the most up-to-date SonicOne technical information and they also have the ability to schedule a surgical evaluation directly through the app."
About Misonix
Misonix, Inc. designs, develops, manufactures and markets therapeutic ultrasonic medical devices. Misonix's therapeutic ultrasonic platform is the basis for several innovative medical technologies. Addressing a combined market estimated to be in excess of $1.5 billion annually; Misonix's proprietary ultrasonic medical devices are used for wound debridement, cosmetic surgery, neurosurgery, laparoscopic surgery, and other surgical and medical applications. Additional information is available on the Company's Web site at www.misonix.com.
Misonix Contact:
Richard Zaremba
631-694-9555
invest@misonix.com Â
